Research study Program year 2024 Source: CMS Open Payments

5 Years OLE Phase II Trial in PPP

Research payments

$518,386

101 payments

Through program year 2024, $518,386 in research payments was reported against 5 Years OLE Phase II Trial in PPP, across 101 payments.

Paid by (largest first): Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim RCV GmbH & Co KG
ClinicalTrials.gov: No trial number was reported for this study

By program year

5 rows

Year	Kind	Amount	Payments
2024	Research	$83,952	6
2023	Research	$38,788	17
2022	Research	$209,091	25
2021	Research	$183,327	45
2020	Research	$3,228	8

Breakdown

Who paid Research payments · program years 2020–2024

Boehringer Ingelheim Pharmaceuticals, Inc. $497,188 49 payments
Boehringer Ingelheim RCV GmbH & Co KG $21,198 52 payments

Who received the money Research payments · program years 2020–2024

Univ Of Missouri Health Care Teaching hospital · MO $131,781 4 payments
Menter Dermatology Research Institute Organisation paid for research $79,067 15 payments
U Of Utah Neuropsychiatric Institute Teaching hospital · UT $62,264 3 payments
University of Pittsburgh Physicians Organisation paid for research $49,765 4 payments
Total Skin And Beauty Dermatology Center Pc Organisation paid for research $47,133 14 payments
Alpesh D Desai DO Pllc Organisation paid for research $32,160 3 payments
Windsor Dermatology Pc Organisation paid for research $26,982 3 payments
Schweiger Dermatology Group-East Windsor Organisation paid for research $20,893 2 payments
Alpesh D Desai DO PLLC Menter Dermatology Research Institite LLC Organisation paid for research $15,952 1 payment
Washington University Of Medicine In St Louis Admin Organisation paid for research $12,036 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

6 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.